skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:033175/0553   Pages: 6
Recorded: 06/10/2014
Attorney Dkt #:P-221
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Total properties: 3
1
Patent #:
Issue Dt:
04/28/2009
Application #:
11789300
Filing Dt:
04/24/2007
Publication #:
Pub Dt:
10/25/2007
Title:
DIALKYLPHENYL COMPOUNDS HAVING BETA2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY
2
Patent #:
Issue Dt:
03/30/2010
Application #:
12406283
Filing Dt:
03/18/2009
Publication #:
Pub Dt:
07/09/2009
Title:
DIALKYLPHENYL COMPOUNDS HAVING BETA2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY
3
Patent #:
Issue Dt:
03/13/2012
Application #:
12701108
Filing Dt:
02/05/2010
Publication #:
Pub Dt:
06/03/2010
Title:
DIALKYLPHENYL COMPOUNDS HAVING BETA2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY
Assignor
1
Exec Dt:
05/31/2014
Assignee
1
901 GATEWAY BOULEVARD
SOUTH SAN FRANCISCO, CALIFORNIA USA 94080
Correspondence name and address
JEFFREY A. HAGENAH
PATENT DEPARTMENT
THERAVANCE BIOPHARMA US, INC.
901 GATEWAY BOULEVARD
SOUTH SAN FRANCISCO, CALIFORNIA 94080

Search Results as of: 06/19/2024 09:29 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT